Axel Svedbom
Overview
Explore the profile of Axel Svedbom including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
341
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wecker H, Svedbom A, Orrego F, Ziehfreund S, Stahle M, Zink A
Acta Derm Venereol
. 2025 Jan;
105:adv41221.
PMID: 39749390
The comorbidity cycle between psoriasis and addictions remains unclear. The study aimed to investigate the cumulative incidence of addictions in psoriasis patients and controls in the Stockholm Psoriasis Cohort (SPC)....
2.
Svedbom A, Mallbris L, Gonzalez-Cantero A, Playford M, Wu C, Mehta N, et al.
JAMA Dermatol
. 2024 Nov;
161(1):81-86.
PMID: 39565616
Importance: Psoriasis is associated with increased cardiovascular risk, but the underlying pathogenic mechanisms remain unclear. Elucidating these mechanisms can help develop treatment strategies and enhance understanding of the link between...
3.
Tayefi M, Svedbom A, Ivert L, Lundqvist M, Ruas J, Bradley M, et al.
Acta Derm Venereol
. 2024 Nov;
104:adv40796.
PMID: 39545373
This cohort study used prospectively collected data from the Swedish national quality registry, SwedAD, to investigate weight gain as a possible side effect of dupilumab treatment for atopic dermatitis. Patients...
4.
Svedbom A, Wennerstrom C, Hjelm F, Tjarnlund A, Stahle M
J Dermatolog Treat
. 2024 Sep;
35(1):2398170.
PMID: 39229963
Background: The advent of biosimilars may increase the frequency of dose escalation with biologics in psoriasis. Objective: To explore the frequency and outcomes of dose escalation with adalimumab etanercept, and...
5.
Bergman D, Roelstraete B, Sun J, Ebrahimi F, Lidstrom R, Svedbom A, et al.
Clin Epidemiol
. 2024 Apr;
16:213-225.
PMID: 38567370
Background: Microscopic colitis (MC) has been associated with several immune-mediated diseases including psoriasis, but earlier research has been limited to psoriasis occurring before MC. Data from large-scale cohort studies investigating...
6.
Lou E, Clemente V, Grube M, Svedbom A, Nelson A, Blome F, et al.
JAMA Netw Open
. 2024 Feb;
7(2):e240407.
PMID: 38411963
Importance: Platinum-based chemotherapy is the backbone of standard-of-care treatment for patients with advanced-stage, high-grade serous carcinoma (HGSC), the most common form of ovarian cancer; however, one-third of patients have or...
7.
Dalen J, Svedbom A, Hernlund E, Olofsson T, Black C
Adv Ther
. 2023 Aug;
40(10):4657-4674.
PMID: 37599341
Introduction: Treatment persistence is a proxy for efficacy, safety and patient satisfaction, and a switch in treatment or treatment discontinuation has been associated with increased indirect and direct costs in...
8.
Svedbom A, Stahle M
Acta Derm Venereol
. 2023 Aug;
103:adv7138.
PMID: 37584504
No abstract available.
9.
Lou E, Clemente V, Grube M, Svedbom A, Nelson A, Blome F, et al.
bioRxiv
. 2023 Jul;
PMID: 37425832
Background: The tumor stroma is composed of a complex network of non-cancerous cells and extracellular matrix elements that collectively are crucial for cancer progression and treatment response. Within the realm...
10.
Svedbom A, Stahle M
J Invest Dermatol
. 2023 May;
143(12):2529-2532.e1.
PMID: 37257639
No abstract available.